Melbourne-based startup Lyrebird Well being has lately raised $12 million in new funding from a enterprise spherical led by 5 V Capital and United Kingdom-based Octopus Ventures, with participation from Startmate.
Launched in 2023, it affords a generative AI-powered scientific documentation software for common practitioners. Its AI scribe has been built-in into market-leading EMR techniques in Australia, resembling Best Practice and Gentu.
WHAT IT’S FOR
In a weblog submit, Lyrebird Well being shared that it’s going to utilise its contemporary funds for world enlargement, beginning in the UK.
In February, the startup introduced its first UK partnership with Alder Hey Youngsters’s NHS Basis Belief for a phased implementation of its AI scribe.
“With this increase, we’ll deepen our funding in product high quality, privateness, and security,” founder Kai Van Lieshout added.
MARKET SNAPSHOT
Fellow AI scribe developer, Heidi Well being, additionally based mostly in Melbourne, raked in nearly $17 million in Series A funding in March. The startup stated these proceeds will go to creating new capabilities of its AI scribe, resembling pre-chart abstract creation. Heidi also worked with Telstra Health to launch its scientific documentation software in February.
In the meantime, Lyrebird additionally lately secured a partnership with King’s Hospital in Dubai and introduced the combination of its AI software into the pre-consultation platform of Sydney-based well being tech firm HealthShare.
In August final yr, outpatient departments throughout Gold Coast Health in Queensland underwent the primary stage trial of Lyrebird’s AI scribe.
Trending Merchandise
